
MARKET PULSE The Fed Wants Higher Rates. It Also Worries About What AI Borrowed. The Fed's October minutes paired two worries: inflation that needs more hikes, and risky AI debt. Almost all officials said more rate increases would likely be appropriate. They also listed AI debt among the risks to financial stability. Nvidia (NVDA) opened higher after its report, then fell about 3%, a sign that strong results no longer settle the debate. The S&P 500 slipped about 0.2%. The Dow fell about 1.1%, and the Nasdaq rose about 0.4%. The 10-year Treasury yield eased to about 5.07%. UnitedHealth's slide weighed heavily on the price-weighted Dow, which fell far more than the broader S&P 500. Housing showed where higher rates bite first. Building permits fell 7.4% in October. Pending home sales hit a record low. Starts rose 9.9%, a gain within the Census margin of error. Nearly half of U.S. homebuilders are now cutting prices. After the close, Palo Alto Networks (PANW) beat forecasts and raised its revenue outlook, and its shares jumped about 12% in late trading. Anthropic reportedly priced its IPO at $83 a share, above its range. Investor Signal Higher rates are landing first on housing and on debt-funded AI projects, two areas that depend on cheap credit. If permits rebound with the 10-year above 5%, housing has adjusted. Further declines would point to a wider drag on growth.
PREMIER FEATURE Lately Every Top Stock List Has Started Looking the Same.Nothing wrong with Nvidia, Tesla, or SpaceX, but we believe there are plenty of other top-quality opportunities for investors willing to dig into the details. That's why our MarketBeat analysts built an all-new list of the 5 Best Stocks to Buy Now. Every company on the list: - Worth at least $5 billion
- Strong fundamentals
- Strong growth prospects ahead
You'll get the full bull case, and the full bear case, for each stock. Every opportunity, every risk, every factor we considered. So you can invest with confidence. The report is called 5 Stocks to Buy Now, and it's yours free today. Send My Free Report
FED WATCH Almost All Fed Officials Saw More Hikes. A Couple Floated a Bigger One. October's push for higher rates was broader than the two dissents suggested. The minutes say "some participants" favored a quarter-point increase at that meeting, though only two voted for one. A couple floated a bigger December hike if inflation data disappointed. Those views predate October's third straight 0.3% rise in core prices. Governor Christopher Waller said Wednesday the Fed should hike by half a point in December or clearly signal a January hike. Governor Michael Barr expects further increases to be appropriate. The December debate is now about speed. Kalshi's bet on a bigger December hike rose to about 7 cents. It was 5 cents before Waller spoke. Investor Signal The Fed is debating speed now, and the faster camp is bigger than the vote count showed. That matters most for short-term borrowers. A quicker path lifts their costs first. If October's core PCE prices, due before the meeting, rise less than 0.3%, the case for a bigger December hike weakens.
AI CREDIT WATCH The Fed Put AI Debt on Its Risk List. Credit Is Getting Tighter. Almost all officials discussed what happens if AI returns disappoint. Most said AI debt grew fast through "complex and opaque financing structures." Staff warned that off-balance-sheet leases and circular deals could amplify losses. A majority also noted wider spreads for some higher-risk and AI-related borrowers. The Fed's stability report had already counted $1.1 trillion of AI-related debt. The minutes name no company, and they predate Nvidia's (NVDA) report, which disclosed guarantees of up to $118 billion for partners' data center projects. Credit is tightening more broadly, too. Junk-bond spreads widened to 3.43 percentage points Tuesday, from 3.20 last Thursday. Blue Owl (OWL) and other direct lenders reportedly took a $1.3 billion loan banks could not sell, at 96 cents on the dollar. It funds L Catterton's buyout of health platform Fullscript. Investor Signal That favors companies that fund AI spending with their own cash over those relying on leases, guarantees or new debt. The junk index covers far more than AI, so AI-linked bonds are the real test. If they keep widening faster than the index, lenders are pricing the Fed's warning.
FROM OUR PARTNERS 
It's rarely a slow bleed. It's usually one trade that was too big, held too long, hoping it would come back. My Safe Trade Options Formula gives you 5 checks to run before that trade ever happens. Normally $29.97. Free through this link. Protect your account.
HEALTH INSURER WATCH A Medicare Clawback Rule Hit Insurers for a Second Day Washington is retrying a Medicare Advantage audit rule that a court struck down last year, and insurer stocks fell harder on the second day. UnitedHealth (UNH) dropped about 10%. Humana (HUM) lost about 13%. The rule, proposed Monday, would apply audit findings across whole contracts back to 2018 and drop an adjustment insurers say the law requires. The Medicare agency expects to recover about $9 billion a year on average. A judge threw out the 2023 version last year over improper notice. The government's appeal is still pending. Comments on the new rule are due Jan. 19, 2027. Investor Signal This time CMS has proposed the no-adjuster approach outright, which aims to answer the court's notice objection. That puts a possible cash cost on the largest insurers. None had sized its exposure by Wednesday's close. An insurer's own estimate, or an appeals ruling, would show how much of the risk is real.
RETAIL WATCH Three Retailers Booked Tariff Refunds. Investors Paid for Shoppers. Three big retailers booked tariff refunds in their latest quarters. Investors rewarded traffic more than refunds. TJX (TJX) rose about 8% after comparable sales grew 4%, topping its own plan. Its adjusted profit leaves refunds out. Target (TGT) climbed about 4% as comparable customer traffic rose 5%. Lowe's (LOW) raised its sales outlook, but its adjusted profit of $3.10 a share included 34 cents of refunds. Without them, it would have fallen short of forecasts. The stock ended up about 1% after opening lower. Strong spending also feeds the Fed's case, since Barr cited solid consumer spending in the same remarks where he backed more hikes. Investor Signal Refunds are a one-time lift, so investors are paying for traffic. That favors retailers drawing more shoppers. It leaves those leaning on refunds exposed. If Target's traffic keeps rising without refund help, its recovery looks durable. Falling traffic would show the refunds did more of the work.
METALS WATCH Bonds Rallied. Gold, Copper and Bitcoin Fell Anyway. Treasuries rallied while gold, copper, oil and bitcoin all fell, so higher yields alone cannot explain the selling. The 10-year yield slipped about 3 basis points. The dollar index rose slightly, near its highest level in a year. Gold futures fell about 3.5% and touched a one-year low. Silver lost about 5%, and copper fell about 5%. U.S. crude fell about 4.5% as stockpiles rose again. Bitcoin fell about 4% to near $62,500, after going into the week without a steady buyer, and Coinbase (COIN) touched a one-year low. Investor Signal Risk appetite, more than rates, drove this selling. Assets that pay no interest fell even as bond yields eased. The dollar's small gain cannot explain moves that large. Gold and crypto holders face sentiment swings the Fed cannot control. If gold and bitcoin bounce once the dollar eases, the dollar mattered more.
CLOSING LENS Inflation still argues for higher rates, and AI's borrowing now sits among the risks those rates could expose. Investors sold Nvidia (NVDA), insurers and metals, and bought retailers drawing shoppers. Demand is still there. The cost of the money behind it is now the real test.
AI Moves Into the Biotech LabFor most of the AI boom, the money followed the hardware. Chips. Data centers. Cloud. Now the algorithms are walking into the lab. In September, a drug whose target was found by AI, and whose molecule was designed by AI, dosed its first patient in a Phase III trial. A second AI-engineered medicine is in Phase III too. We profiled the 5 companies leading the shift in a new FREE Special Report: AI Moves Into the Biotech Lab. We'll text it straight to your phone. Get the Free Report by Text → |